Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Studying the ShcD and ERK interaction under acute oxidative stress conditions in melanoma cells.

Ahmed SBM, Amer S, Emad M, Rahmani M, Prigent SA.

Int J Biochem Cell Biol. 2019 Jul;112:123-133. doi: 10.1016/j.biocel.2019.05.009. Epub 2019 May 20.

2.

Transcriptional and Post-Translational Targeting of Myocyte Stress Protein 1 (MS1) by the JNK Pathway in Cardiac Myocytes.

Hay JM, Jordan ES, Browne GJ, Bottrill AR, Prigent SA, Dickens M.

J Mol Signal. 2017 Dec 8;12:3. doi: 10.5334/1750-2187-12-3.

3.

The role of the ShcD and RET interaction in neuroblastoma survival and migration.

Mabruk ZA, Ahmed SBM, Thomas AC, Prigent SA.

Biochem Biophys Rep. 2018 Jan 28;13:99-108. doi: 10.1016/j.bbrep.2018.01.007. eCollection 2018 Mar.

4.

Insights into the Shc Family of Adaptor Proteins.

Ahmed SBM, Prigent SA.

J Mol Signal. 2017 May 3;12:2. doi: 10.5334/1750-2187-12-2.

5.

A nuclear export signal and oxidative stress regulate ShcD subcellular localisation: a potential role for ShcD in the nucleus.

Ahmed SB, Prigent SA.

Cell Signal. 2014 Jan;26(1):32-40. doi: 10.1016/j.cellsig.2013.09.003. Epub 2013 Sep 13.

PMID:
24036217
6.

Post-transcriptional regulation of VEGF-A mRNA levels by mitogen-activated protein kinases (MAPKs) during metabolic stress associated with ischaemia/reperfusion.

Miller BW, Hay JM, Prigent SA, Dickens M.

Mol Cell Biochem. 2012 Aug;367(1-2):31-42. doi: 10.1007/s11010-012-1316-9. Epub 2012 May 5.

PMID:
22562302
7.

Activation of ASK1, downstream MAPKK and MAPK isoforms during cardiac ischaemia.

Harding SJ, Browne GJ, Miller BW, Prigent SA, Dickens M.

Biochim Biophys Acta. 2010 Sep;1802(9):733-40. doi: 10.1016/j.bbadis.2010.06.005. Epub 2010 Jun 13.

8.

Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.

Squires MS, Hudson EA, Howells L, Sale S, Houghton CE, Jones JL, Fox LH, Dickens M, Prigent SA, Manson MM.

Biochem Pharmacol. 2003 Feb 1;65(3):361-76.

PMID:
12527329
9.
10.

Identification of receptor tyrosine kinase associating proteins using the yeast two-hybrid system.

Prigent SA.

Methods Mol Biol. 2001;124:251-70. No abstract available.

PMID:
11100481
11.

Modulation of signal-transduction pathways by chemopreventive agents.

Manson MM, Holloway KA, Howells LM, Hudson EA, Plummer SM, Squires MS, Prigent SA.

Biochem Soc Trans. 2000 Feb;28(2):7-12. Review.

PMID:
10816090
12.

The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells.

Warner AJ, Lopez-Dee J, Knight EL, Feramisco JR, Prigent SA.

Biochem J. 2000 Apr 15;347(Pt 2):501-9.

13.

Blocking and suppressing mechanisms of chemoprevention by dietary constituents.

Manson MM, Gescher A, Hudson EA, Plummer SM, Squires MS, Prigent SA.

Toxicol Lett. 2000 Mar 15;112-113:499-505. Review.

PMID:
10720772
14.

Microinjection of anti-p21 antibodies induces senescent Hs68 human fibroblasts to synthesize DNA but not to divide.

Ma Y, Prigent SA, Born TL, Monell CR, Feramisco JR, Bertolaet BL.

Cancer Res. 1999 Oct 15;59(20):5341-8.

15.

Talin contains three similar vinculin-binding sites predicted to form an amphipathic helix.

Bass MD, Smith BJ, Prigent SA, Critchley DR.

Biochem J. 1999 Jul 15;341 ( Pt 2):257-63.

16.

Identification of ErbB3-stimulated genes using modified representational difference analysis.

Edman CF, Prigent SA, Schipper A, Feramisco JR.

Biochem J. 1997 Apr 1;323 ( Pt 1):113-8.

17.

Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway.

Prigent SA, Nagane M, Lin H, Huvar I, Boss GR, Feramisco JR, Cavenee WK, Huang HS.

J Biol Chem. 1996 Oct 11;271(41):25639-45.

18.

Binding of Shc to the NPXY motif is mediated by its N-terminal domain.

Prigent SA, Pillay TS, Ravichandran KS, Gullick WJ.

J Biol Chem. 1995 Sep 22;270(38):22097-100.

19.

NDF/heregulin stimulates the phosphorylation of Her3/erbB3.

Kita YA, Barff J, Luo Y, Wen D, Brankow D, Hu S, Liu N, Prigent SA, Gullick WJ, Nicolson M.

FEBS Lett. 1994 Jul 25;349(1):139-43.

21.

ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor.

Soltoff SP, Carraway KL 3rd, Prigent SA, Gullick WG, Cantley LC.

Mol Cell Biol. 1994 Jun;14(6):3550-8.

23.

Expression of the ERBB3 gene product in breast cancer.

Lemoine NR, Barnes DM, Hollywood DP, Hughes CM, Smith P, Dublin E, Prigent SA, Gullick WJ, Hurst HC.

Br J Cancer. 1992 Dec;66(6):1116-21.

24.

The erbB-3 gene in human pancreatic cancer.

Lemoine NR, Lobresco M, Leung H, Barton C, Hughes CM, Prigent SA, Gullick WJ, Klöppel G.

J Pathol. 1992 Nov;168(3):269-73.

PMID:
1361525
25.

Expression of the c-erbB-3 protein in normal human adult and fetal tissues.

Prigent SA, Lemoine NR, Hughes CM, Plowman GD, Selden C, Gullick WJ.

Oncogene. 1992 Jul;7(7):1273-8.

PMID:
1377811
26.

The type 1 (EGFR-related) family of growth factor receptors and their ligands.

Prigent SA, Lemoine NR.

Prog Growth Factor Res. 1992;4(1):1-24. Review.

PMID:
1355372
27.

Supplemental Content

Loading ...
Support Center